Bio Path | BPTH - Caixa e Equivalentes





Caixa e Equivalentes Alterar Data
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Baxter International USD 2.02B 51M 2026-03
Bio Path 13.65M 3.37M 2022-09
Cipla INR 7.96B 39.9M 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 90.6M 83.14M 2025-12
CSL USD 2.16B 633M 2025-06
Grifols EUR 979.78M 334.84M 2024-12
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12